IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)

Clinical trial NCT04826159 · COMPLETED

Trial details

NCT number: NCT04826159
Sponsor: Imbria Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Diabetic Cardiomyopathies HFpEF - Heart Failure With Preserved Ejection Fraction

Start date: 2021-04-21
Primary completion: 2024-08-06
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.